Get your Clinical Diabetes paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.1
Authored by Sumalatha Gangadhar | Published on 3 August, 2026
Submitting to Clinical Diabetes goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Clinical Diabetes guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
It is a manuscript shell aligned to Clinical Diabetes. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Clinical Diabetes journal page before you draft.
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Clinical Diabetes guide for authors lists, and cite figures and tables in order.
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Clinical Diabetes guide for authors before you submit.
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through ScholarOne (Manuscript Central).
| Element | Clin Diabetes requirement |
|---|---|
| Abstract | Feature Articles: Very short (2-4 sentences) brief summary required (not a traditional abstract). Authors may also include a short, bulleted list of up to four key points (optional). Case Studies: Structured format required with sections: 1. Case study title, 2. Your name, 3. Brief case presentation (including symptoms at presentation, significant history, physical exam, and lab results), 4. Questions raised by this case, 5. Commentary, 6. Summary of the 'clinical pearls' exemplified by this case, 7. A brief list of references or suggested readings. Clinical Pharmacology Update: Structured template required with sections: 1. Introduction, 2. Indications (label and off-label), 3. Mechanism of action, 4. Potential advantages, 5. Potential disadvantages, 6. Cost, 7. Comments, 8. Bottom line. Translating Research to Practice: Structured format required with sections: 1. Title of your article, 2. Citation for the research study, 3. Reviewed by (your name), 4. Summary of the research article, 5. Discussion of the significance of this research, 6. References. No specific word limits stated for most article types except Feature Articles (2-4 sentences) |
| Main text | Feature Articles: Approximately 3,000 to 6,000 words in length (no firm restriction stated). Case Studies: Approximately 800-1,600 words. Clinical Pharmacology Update: 500-1,000 words. Commentary: Approximately 800 words. Editorial: Approximately 800 words. Letter to the Editor: Brief (≤800 words). Perspectives in Clinical Diabetes: Approximately 2,000-4,000 words. Practical Pointers: Approximately 2,400-4,000 words. Translating Research to Practice: Approximately 1,600 words |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | Optional. Feature Articles may include a short, bulleted list of up to four key points. No mention of MeSH terms or mandatory keywords for any article type |
| References | Numbered citation style. References should be numbered in the order they are cited in the text. Reference numbers in the text should be in normal type and in parentheses (e.g., 'In the study by Norton et al. (23)...'). For articles with fewer than seven authors, include all author names; for those with seven or more authors, include the first three names followed by 'et al.' Journal titles should be abbreviated as in the National Library of Medicine's List of Journals Indexed for Medline. Authors should follow Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers (8th edition) and AMA Manual of Style (10th edition) for units of measure. EndNote or footnote/endnote functions should not be used |
| Peer review | Single-blind/single-anonymous. According to ADA journals' official reviewer information page: 'ADA journals use a single-blinded review process: authors are blinded to the identities of the editors and reviewers responsible for the independent peer review of their manuscripts, but not vice versa.' Note: 'All Perspectives in Clinical Diabetes papers (whether invited or by query) are subject to peer review.' |
| Submission | mc.manuscriptcentral.com/clinical-diabetes |
Read the Clinical Diabetes guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Clinical Diabetes in under a page.
Skim two or three recent Clin Diabetes papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Clinical Diabetes journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Do one focused pass against the Clinical Diabetes guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through ScholarOne (Manuscript Central).